Darren Woodside, Ph.D., is an Associate Director of the Molecular Cardiology Research Laboratories at THI. Previous positions included Associate Director of Drug Discovery at Encysive Pharmaceuticals. He was awarded his Ph.D. from the University of Texas MD Anderson Cancer Center's Department of Immunology and was a post-doctoral fellow at The Scripps Research Institute. Show full bio
Dr. Woodside’s research centers around the role that cell adhesion plays in cardiovascular and autoimmune diseases, and the development of novel means to identify and treat these diseases. He has authored numerous publications, served on Editorial Review Boards, and currently chairs the NIH Innovative Immunology Study Section.
Queen's University at Kingston
University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences
The Scripps Research Institute
Honors, Awards and Memberships
Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral...
THI Researchers Introduce Method for Earlier Identification of Patients at High Risk of Heart Attack or Stroke Due to Inflamed Arterial Plaque
Researchers in the Department of Molecular Cardiology at the Texas Heart Institute (THI), in collaboration with investigators at Texas Children’s...